SGK 	SGK 	 NNP	B-NP
,  	,  	 ,	O
renal  	renal  	 JJ	B-NP
function  	function  	 NN	I-NP
and  	and  	 CC	O
hypertension  	hypertension  	 JJ	B-NP
Serum-  	Serum-  	 JJ	I-NP
and  	and  	 CC	O
glucocorticoid-inducible  	glucocorticoid-inducible  	 JJ	B-NP
kinase  	kinase  	 NN	I-NP
1  	1  	 CD	O
( 	( 	 -LRB-	O
SGK1 	SGK1 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
expressed  	expressed  	 VBN	O
following  	following  	 VBG	O
cell  	cell  	 NN	O
stress  	stress  	 NN	O
and  	and  	 CC	O
exposure  	exposure  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
hormones  	hormones  	 NNS	O
including  	including  	 VBG	B-NP
glucocorticoids  	glucocorticoids  	 NNS	I-NP
and  	and  	 CC	O
mineralocorticoids 	mineralocorticoids 	 NN	B-NP
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
activated  	activated  	 VBN	O
by  	by  	 IN	O
insulin  	insulin  	 NN	O
and  	and  	 CC	O
growth  	growth  	 NN	B-NP
factors  	factors  	 NNS	I-NP
via  	via  	 IN	O
phosphatidylinositol-3-kinase  	phosphatidylinositol-3-kinase  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
3-phosphoinositide-dependent  	3-phosphoinositide-dependent  	 CD	O
kinase  	kinase  	 CD	O
PDK1 	PDK1 	 CD	O
.  	.  	 .	O
SGK1  	SGK1  	 NNP	B-NP
enhances  	enhances  	 VBZ	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
ion  	ion  	 JJ	O
channels  	channels  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
ENaC 	ENaC 	 NNP	B-NP
,  	,  	 ,	O
TRPV5 	TRPV5 	 NNP	B-NP
,  	,  	 ,	O
ROMK 	ROMK 	 NNP	B-NP
,  	,  	 ,	O
KCNE1 	KCNE1 	 NNP	B-NP
/ 	/ 	 NNP	O
KCNQ1  	KCNQ1  	 NNP	B-NP
and  	and  	 CC	O
ClCKb 	ClCKb 	 JJ	O
;  	;  	 :	O
carriers  	carriers  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
NHE3 	NHE3 	 NNP	B-NP
,  	,  	 ,	O
NKCC2 	NKCC2 	 NNP	B-NP
,  	,  	 ,	O
NCC  	NCC  	 NNP	B-NP
and  	and  	 CC	O
SGLT1 	SGLT1 	 NNP	B-NP
;  	;  	 :	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
Na+ 	Na+ 	 CD	O
/ 	/ 	 CD	O
K+-ATPase 	K+-ATPase 	 CD	O
.  	.  	 .	O
SGK1  	SGK1  	 NNP	B-NP
contributes  	contributes  	 VBZ	O
to  	to  	 TO	O
Na+  	Na+  	 CD	O
retention  	retention  	 NN	O
and  	and  	 CC	O
K+  	K+  	 CD	O
elimination  	elimination  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
kidney  	kidney  	 NN	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
mineralocorticoid  	mineralocorticoid  	 JJ	B-NP
stimulation  	stimulation  	 NN	I-NP
of  	of  	 IN	O
salt  	salt  	 JJ	O
appetite 	appetite 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
certain  	certain  	 JJ	O
SGK1  	SGK1  	 CD	B-NP
gene  	gene  	 NN	I-NP
variant  	variant  	 NNS	I-NP
( 	( 	 -LRB-	O
combined  	combined  	 JJ	O
polymorphisms  	polymorphisms  	 NN	B-NP
in  	in  	 IN	O
intron  	intron  	 CD	B-NP
6  	6  	 CD	O
[ 	[ 	 -LRB-	O
I6CC 	I6CC 	 NNP	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
in  	in  	 IN	O
exon  	exon  	 CD	B-NP
8  	8  	 CD	O
[ 	[ 	 -LRB-	O
E8CC 	E8CC 	 NNP	O
/ 	/ 	 NNP	O
CT 	CT 	 NNP	B-NP
] 	] 	 -RRB-	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
moderately  	moderately  	 RB	O
enhanced  	enhanced  	 JJ	O
blood  	blood  	 NN	O
pressure 	pressure 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
SGK1  	SGK1  	 JJ	B-NP
gene  	gene  	 NN	I-NP
variant  	variant  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
affect  	affect  	 VB	O
3 	3 	 CD	O
% 	% 	 NN	O
-5 	-5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
whites  	whites  	 NNS	O
and  	and  	 CC	O
some  	some  	 DT	O
10 	10 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
Africans 	Africans 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
gene  	gene  	 NN	B-NP
variant  	variant  	 NNS	I-NP
sensitizes  	sensitizes  	 VBP	O
the  	the  	 DT	O
carriers  	carriers  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
hypertensive  	hypertensive  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
hyperinsulinemia 	hyperinsulinemia 	 NN	I-NP
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
SGK1  	SGK1  	 JJ	B-NP
gene  	gene  	 NN	I-NP
variant  	variant  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
body  	body  	 NN	O
mass  	mass  	 NN	O
index 	index 	 NN	O
,  	,  	 ,	O
presumably  	presumably  	 RB	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
enhanced  	enhanced  	 JJ	O
SGLT1  	SGLT1  	 CD	B-NP
activity  	activity  	 NN	I-NP
with  	with  	 IN	O
accelerated  	accelerated  	 FW	O
intestinal  	intestinal  	 FW	B-NP
glucose  	glucose  	 FW	I-NP
absorption 	absorption 	 FW	I-NP
.  	.  	 .	O
Obesity  	Obesity  	 NNP	B-NP
predisposes  	predisposes  	 VBD	O
the  	the  	 DT	O
carriers  	carriers  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
gene  	gene  	 NN	B-NP
variant  	variant  	 NN	I-NP
to  	to  	 TO	O
development  	development  	 NN	O
of  	of  	 IN	O
type  	type  	 NN	O
2  	2  	 CD	O
diabetes 	diabetes 	 NN	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
SGK1  	SGK1  	 FW	B-NP
stimulates  	stimulates  	 FW	O
coagulation 	coagulation 	 FW	B-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
SGK1  	SGK1  	 NNP	B-NP
may  	may  	 MD	O
participate  	participate  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
metabolic  	metabolic  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
or  	or  	 CC	O
syndrome  	syndrome  	 NN	O
X 	X 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
condition  	condition  	 NN	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
coincidence  	coincidence  	 NN	O
of  	of  	 IN	O
essential  	essential  	 JJ	B-NP
hypertension 	hypertension 	 NN	I-NP
,  	,  	 ,	O
procoagulant  	procoagulant  	 JJ	B-NP
state 	state 	 NN	I-NP
,  	,  	 ,	O
obesity 	obesity 	 NN	B-NP
,  	,  	 ,	O
insulin  	insulin  	 NN	O
resistance  	resistance  	 NN	O
and  	and  	 CC	O
hyperinsulinemia 	hyperinsulinemia 	 NN	B-NP
.  	.  	 .	O
